… gas-based power plants. Biocon Biocon has received Indian regulatory … pens and cartridges through Biocon’s subsidiary. Glenmark Pharma … multiple myeloma, a blood cancer that affects bone marrow. … Watch: ITC, HCL Tech, Biocon, Vodafone Idea, Torrent Power, …

… ), HCLTech (NSE: HCLTECH), Biocon (NSE: BIOCON), Torrent Power (NSE: TORNTPOWER … Full List Here. Biocon (NSE: BIOCON) Biocon said it has received … results from a new cancer drug being tested on … difficult form of blood cancer, relapsed or refractory multiple …

… MW gas-based power plants. Biocon Biocon has received approval from Indian … above, alongside diet and exercise. Biocon Pharma, the company’s wholly … refractory multiple myeloma, a blood cancer affecting bone marrow. UGRO Capital …

… around ₹259.99 crore. Biocon | The company said it has … its wholly owned subsidiary Biocon Pharma has secured clearance for … a biotechnology company focused on cancer treatments, has announced positive … — a type of blood cancer that affects plasma cells in …

… by those with node-positive cancer, according to findings presented … with HER2-positive operable breast cancer, 2400 patients received adjuvant … Jazz Pharmaceuticals, AbbVie, BridgeBio, BioNTech, Biocon, Novartis, Eisai, Pfizer, Stemline Therapeutics …

… told Mint. Overall, Biocon reported consolidated revenue of … commitments related to Biocon and its subsidiaries,” … of launch quantities of cancer drug Lenalidomide (Revlimid) … cancer drugs Dasatinib, and anti-diabetes medicine Liraglutide in the UK. Biocon …

… Kiran Mazumdar-Shaw, chairperson, Biocon Group, told investors in … supplies in border states Biocon Biologics acquired US drugmaker … patient access." Biocon is a global biopharmaceuticals … chronic segments like diabetes, cancer and autoimmune.  Also read: …

… million each in FY25," Biocon Group Chairperson Kiran Mazumdar-Shaw … illnesses such as cancer, rheumatoid arthritis and psoriasis. Biocon's total … biosimilars business rose 4.5%. Biocon said its focus is also …

… (Reuters) -Indian biopharma firm Biocon’s profit more than doubled … million each in FY25,” Biocon Group Chairperson Kiran Mazumdar-Shaw … such as cancer, rheumatoid arthritis and psoriasis. Biocon’s total … business rose 4.5%. Biocon said its focus is also …

… where cervical cancer prevalence is high. Cervical Cancer Treatment Regional … Pharmaceuticals, Inc. AstraZeneca PLC Biocon Ltd Bristol-Myers Squibb Company … SCC) Adenocarcinoma Adenosquamous Carcinoma Cervical Cancer Treatment Market by Treatment Type …